This profile was last updated on . .
Is this you? Claim your profile.
ArQule , Inc.
One Wall Street
Burlington, Massachusetts 01803
ArQule, Inc. is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics. The Company’s product is ARQ 197, an orally administered inhibitor of the c-Met receptor tyrosine kinase. ARQ 197 is being evaluated as ... more
Vice President, Medicinal Chemistry
Cambridge Healthtech Institute
Mastering Medicinal Chemistry - Day 1 - Molecular Med Tri-Con 2012
Next-Gen Kinase Inhibitors
SocialDiligence | Social networks, photos, videos, email address, publications and more ...